Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1989-8-10
|
pubmed:abstractText |
We studied the relationship between endogenous insulin secretion and fasting levels of plasma free fatty acids (FFA), plasma acetoacetate plus plasma 3-hydroxybutyrate (total ketone bodies), blood glucose, and HbA1 in 132 diabetic outpatients treated with conventional insulin regimens. Patients were divided into four groups according to plasma C-peptide concentration after intravenous stimulation with glucagon: one group with C-peptide stimulation less than 0.06 nmol/l, one group with C-peptide stimulation 0.06- less than 0.32 nmol/l, one group with C-peptide stimulation 0.32- less than 0.60 nmol/l, and one group with C-peptide stimulation greater than 0.60 nmol/l. According to clinical criteria the prevalence of insulin-dependent diabetes mellitus was approximately 90% in patients with C-peptide stimulation less than 0.32 nmol/l, approximately 25% in patients with C-peptide stimulation from 0.32- less than 0.60 nmol/l, and approximately 10% in patients with C-peptide stimulation greater than 0.60 nmol/l. All metabolic variables were significantly higher in patients without detectable C-peptide in plasma when compared to values found in patients with C-peptide stimulation from 0.06- less than 0.32 nmol/l. These two patient groups also had similar peripheral plasma free insulin levels and were comparable according to age, sex, and body mass index.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/C-Peptide,
http://linkedlifedata.com/resource/pubmed/chemical/Fatty Acids, Nonesterified,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Ketone Bodies
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0036-5513
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
49
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
337-43
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2662383-Adult,
pubmed-meshheading:2662383-Aged,
pubmed-meshheading:2662383-Blood Glucose,
pubmed-meshheading:2662383-C-Peptide,
pubmed-meshheading:2662383-Diabetes Mellitus, Type 1,
pubmed-meshheading:2662383-Diabetes Mellitus, Type 2,
pubmed-meshheading:2662383-Fasting,
pubmed-meshheading:2662383-Fatty Acids, Nonesterified,
pubmed-meshheading:2662383-Female,
pubmed-meshheading:2662383-Hemoglobin A, Glycosylated,
pubmed-meshheading:2662383-Humans,
pubmed-meshheading:2662383-Insulin,
pubmed-meshheading:2662383-Islets of Langerhans,
pubmed-meshheading:2662383-Ketone Bodies,
pubmed-meshheading:2662383-Male,
pubmed-meshheading:2662383-Middle Aged
|
pubmed:year |
1989
|
pubmed:articleTitle |
Metabolic effect of islet B-cell function in insulin-treated diabetes.
|
pubmed:affiliation |
Medical Department, Fredericia Hospital, Denmark.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|